NEPHROPLUS · Healthcare · Medical Care Facilities
Composite scorecard: 48/100 — Quality 63 · Valuation 26
| Share price | ₹628.80 |
| Market cap | ₹6,512 Cr |
| P/E ratio | 80.0 |
| P/B ratio | 5.8 |
| ROCE | 13.5% |
| Book value | ₹111.27 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹999 Cr | ₹77 Cr | 22.0% |
| 2025 | ₹756 Cr | ₹67 Cr | 22.0% |
| 2024 | ₹566 Cr | ₹35 Cr | 18.0% |
| 2023 | ₹437 Cr | ₹-12 Cr | 11.0% |
| 2022 | ₹318 Cr | ₹-21 Cr | 5.0% |
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.